| Application no. and date | 03749892.0 (espacenet) (Federated) (European Patent Register), 20030513 | | Patent/reg. no. and date | DK/EP 1505965, 20060802 | | Publication date | 20050216 | | Priority no. and date | US 380373 P, 20020514, US 395014 P, 20020711 | | EP pub. no. and date |
EP 1505965 20050216 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 127501 | | Inventor | WEBB, Randy, Lee, 17 Honeyman Drive
Flemington, NJ 08822, US,
MALININ, Alex, 9 Windy Cliff Place, Apt. H.
Cockeysville, MD 21030, US,
SEREBRUANY, Victor, L., 14110 Rover Mill Road
West Friendship, MD 21794, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/41 (2006.01) , A61P 7/02 (2006.01) | | Title | Anvendelse af metaboliten af valsartan til inhibering af blodpladeaggregering | | Int. application no. | EP2003004997 | | Int. publication no. | WO2003094915 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
